Infliximab Treatment for Intravenous Immunoglobulin-resistant Kawasaki Disease: a Multicenter Study in Korea

BACKGROUND AND OBJECTIVES: We investigated the status of infliximab use in intravenous immunoglobulin (IVIG)-resistant Kawasaki disease (KD) patients and the incidence of coronary artery aneurysms (CAAs) according to treatment regimens. METHODS: Between March 2010 and February 2017, 16 hospitals par...

Descripción completa

Detalles Bibliográficos
Autores principales: Hur, Gyu, Song, Min Seob, Sohn, Sejung, Lee, Hyoung Doo, Kim, Gi Beom, Cho, Hwa Jin, Yoon, Kyung Lim, Joo, Chan Uhng, Hyun, Myung Chul, Kim, Chul Ho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Cardiology 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6351283/
https://www.ncbi.nlm.nih.gov/pubmed/30468032
http://dx.doi.org/10.4070/kcj.2018.0214

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6351283/
https://www.ncbi.nlm.nih.gov/pubmed/30468032
http://dx.doi.org/10.4070/kcj.2018.0214

Ejemplares similares